‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
What about the First Home Savings Account?
10 essential considerations when selling your business
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall